INFLAMACIÓN Y BIOMARCADORES
University of Tasmania
Hobart, AustraliaPublikationen in Zusammenarbeit mit Forschern von University of Tasmania (4)
2017
-
Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study
Pharmacogenomics Journal, Vol. 17, Núm. 4, pp. 312-318
2016
2012
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562